researchers decided to call the still-active X genes EXITS: escape from X-inactivation tumor suppressors. Across twenty-one different sorts of cancers, five of these EXITS genes were more frequently mutated in men than in women. Being male, in other words, was very much a part of what was killing them. And presumably, as we slowly figure out how to develop treatments for those sorts of cancers, we may well be trying to make those cancer-ridden male bodies essentially more female.
